Trials / Completed
CompletedNCT06100458
Use of Continence Care Protocol in UK Nursing Homes.
Use of Skin and Leakage Protocol and Its Impact on Continence Care at Nursing Homes in the UK.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Essity Hygiene and Health AB · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a retrospective cohort study. In the investigation the clinical use of the Skin and leakage protocol (SLEP) is to be investigated. The SLEP is a generic digital diary form filled out to give information about the current status of continence care among care home residents. The SLEP tracks the number of leakage occurrences and daily skin health over a period of time with the purpose of assisting care staff in making decisions regarding continence care. The SLEP has been introduced at several United kingdom National Health Service care homes and with this investigation the investigators want to retrospectively analyse the data to determine the clinical usefulness of the form. The primary objective of the study is to describe any changes in product leakage rate at the baseline and follow up time period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Skin and leakage protocol | The skin and leakage protocol have been developed by the sponsor with the aim to offer a tool that can aid care providers in identifying problems in continence care and follow up the effect of any care interventions to remedy these problems. The protocol is a digital diary tool that tracks both the instances of urine leaking out of an absorbing incontinence product onto clothes and bedsheets, and any apparent skin changes in the area covered by the product. The protocol is in clinical use at the care homes were the subjects are residing. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2023-02-02
- Completion
- 2023-02-02
- First posted
- 2023-10-25
- Last updated
- 2023-10-25
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06100458. Inclusion in this directory is not an endorsement.